Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02061332
Title DC Vaccine for Patients With Ductal Carcinoma In Situ
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Pennsylvania
Indications

Her2-receptor positive breast cancer

Therapies

HER2-pulsed DC1 vaccine

Age Groups: adult
Covered Countries USA


No variant requirements are available.